Cigarette Smoking
214
20
24
161
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
72 trials with published results (34%)
Research Maturity
161 completed trials (75% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
5.1%
11 terminated out of 214 trials
93.6%
+7.1% vs benchmark
7%
16 trials in Phase 3/4
45%
72 of 161 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 161 completed trials
Clinical Trials (214)
Varenicline for Smoking Reduction in Veterans Not Ready To Quit
Free Samples for Health
The Effectiveness of Smoking Cessation in Prediabetic Smokers
Switch or Quit R01
Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures
Smoking, Stress, HIV and Mobile Technology
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
Concurrent vs. Sequential Cessation of Dual Cigarette and E-cigarette Use
Testing the ETM: Examination and Comparison of Different Methods
Remote Interventions for Menthol Cigarette Use
Effects of Tax Proposals and Cigarette Availability on Tobacco Purchasing
Beta-Adrenergic Modulation of Drug Cue Reactivity
Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults
Examining the Generality of Laboratory-based Findings and Their Moderators in the ITC Study
RTMS Targets Neural Circuits for Smoking Cessation
Menthol, Inflammation, and Nicotine Transition Study
Effect of Helpers Program On-line Training on Smoking Relapse and Social Networks
Mapping Brain Glutamate in Humans: Sex Differences in Cigarette Smokers
Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder